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Abstract
The cell intrinsic programming that regulates mammalian primordial germ cell (PGC) development in the pre-gonadal stage
is challenging to investigate. To overcome this we created a transgene-free method for generating PGCs in vitro (iPGCs)
from mouse embryonic stem cells (ESCs). Using labeling for SSEA1 and cKit, two cell surface molecules used previously to
isolate presumptive iPGCs, we show that not all SSEA1+/cKit+ double positive cells exhibit a PGC identity. Instead, we
determined that selecting for cKit
bright cells within the SSEA1+ fraction significantly enriches for the putative iPGC
population. Single cell analysis comparing SSEA1+/cKit
bright iPGCs to ESCs and embryonic PGCs demonstrates that 97% of
single iPGCs co-express PGC signature genes Blimp1, Stella, Dnd1, Prdm14 and Dazl at similar levels to e9.5–10.5 PGCs,
whereas 90% of single mouse ESC do not co-express PGC signature genes. For the 10% of ESCs that co-express PGC
signature genes, the levels are significantly lower than iPGCs. Microarray analysis shows that iPGCs are transcriptionally
distinct from ESCs and repress gene ontology groups associated with mesoderm and heart development. At the level of
chromatin, iPGCs contain 5-methyl cytosine bases in their DNA at imprinted and non-imprinted loci, and are enriched in
histone H3 lysine 27 trimethylation, yet do not have detectable levels of Mvh protein, consistent with a Blimp1-positive pre-
gonadal PGC identity. In order to determine whether iPGC formation is dependent upon Blimp1, we generated Blimp1 null
ESCs and found that loss of Blimp1 significantly depletes SSEA1/cKit
bright iPGCs. Taken together, the generation of Blimp1-
positive iPGCs from ESCs constitutes a robust model for examining cell-intrinsic regulation of PGCs during the Blimp1-
positive stage of development.
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Introduction
The molecular events that regulate cell fate decisions in post-
implantation mammalian embryonic development are largely
uncharacterized due to the challenge in identifying and isolating
small populations of specific precursor cells that are develop-
mentally transient in the early embryo. In particular, precursors
of the germ cell lineage are initially set aside as four to six cells in
the murine embryonic epiblast, which proliferate and migrate
through the primitive streak to generate the initial founder
primordial germ cell (PGC) pool of approximately forty cells at
the base of the allantois at embryonic (e) day e7.5 [1,2]. The
PGCs migrate out of the allantois and into the embryonic hindgut
endoderm at e8.0–8.5 where they continue to proliferate and
begin to accumulate nuclear histone H3 lysine 27 trimethylation
(H3K27m3) [3]. By e10.5–e11.0 a single embryo has approx-
imately 1,000–2,000 PGCs, which exit the hindgut and begin
colonization of the indifferent gonad and express Mvh protein
[3,4,5].
The transcription factors that specify and sustain PGC identity
prior to gonadal colonization are not well understood. One of the
most characterized regulators of PGC fate is the transcriptional
repressor B-lymphocyte induced maturation protein 1 (Blimp1), the
transcriptional product of the PRD1-BF1 and RIZ (PR) domain 1
(Prdm1) gene. Blimp1 expression is detected in epiblast-derived
PGCs and persists until e11.5, when PGCs have colonized the
gonad [2,6]. Loss of one Prdm1 allele significantly reduces PGC
numbers in the allantois, with the loss of both causing almost a
complete loss of PGCs [2]. The major direct target of Blimp1 in
PGCs is hypothesized to be Hoxb1 [7]. However, direct binding of
Blimp1 at the Hoxb1 locus in PGCs has not been demonstrated.
The mechanism by which Blimp1 mediates gene repression is
hypothesized to involve recruitment of the chromatin-remodeling
enzyme Protein arginine methyltransferase 5 (Prmt5) to chromatin
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28960[6]. However, genome-wide analysis of PGC chromatin is
currently not feasible due to the challenge in performing
chromatin immunoprecipitation on small cell numbers, necessi-
tating the development of a scalable model to accurately capture
the Blimp1-positive phase of PGC development.
The differentiation of pluripotent stem cells, including embry-
onic stem cells (ESCs), has emerged as a novel technology for
generating sufficient numbers of embryonic progenitors at-scale to
evaluate embryonic lineage development. A number of methods
for identifying in vitro PGCs (iPGCs) have been described that
mostly involve use of integrated fluorescent reporters, including
Oct4-delta-PE-Gfp [8,9,10,11,12], Stella-Gfp [13,14,15], Dazl-Gfp
[16] and Mvh-LacZ/Rfp transgenes [10,17,18]. A small number of
studies have used Stage Specific Embryonic Antigen 1 (SSEA1) to
enrich for germ cells [19,20], but the identity of PGCs from ESCs
within the SSEA1+ fraction has not been interrogated at a single
cell level. Furthermore, the majority of PGC differentiation studies
have been designed to characterize the post-colonized Blimp1-
negative PGC. Therefore, the goal of the current study is to
generate a robust ESC differentiation system to acquire PGCs in
the Blimp1-positive stage of development for future in-depth
analysis of the pre-gonadal stage.
Results
cKit
bright refines an Oct4+/SSEA1+ iPGC population in
embryoid bodies
To identify pre-gonadal iPGCs with differentiation, we first used
Oct4-Gfp ESCs [21] to generate hanging-drop embryoid bodies
(EBs) containing 300 cells per drop (Figure 1A). EBs could be
maintained for up to 8 days in this system (Figure S1A), but cell
viability decreased rapidly after day 6 from 69% to 19% by day 8
(Figure S1B). Using flow cytometry we show that Gfp is retained in
the majority of cells in the first four days of differentiation
(Figure 1B), reminiscent of sustained Oct4 expression in vivo in
both PGCs and embryonic somatic cells up to e8.5 [22,23]. On
day 5 of differentiation, we observed the emergence of a shoulder
of Gfp
bright cells and the formation of a distinct Gfp+ peak by day
6 (Figure 1B, arrow).
To generate a transgene-free method of iPGC differentiation,
we correlated expression of Oct4 protein in day 6 EBs derived
from V6.5 ESCs with the cell surface marker SSEA1. In the
embryo, SSEA1 is highly expressed on Blimp1-positive stage
PGCs and PGC precursors derived from epiblast stem cells
[24,25]. We found that Oct4 is co-expressed with SSEA1 in small
cell clusters at day 6 of differentiation by immunofluorescence
(Figure 1C). Given that Oct4 and SSEA1 are also expressed by
undifferentiated ESCs, we used the membrane-localized tyrosine
kinase receptor cKit to assist in further defining the iPGC
population within either the SSEA1+ or Oct4+ fractions. cKit is
highly expressed by endogenous PGCs from e7.25 to e13.5
[7,22,26] and is not expressed by epiblast cells [22]. Indeed, flow
cytometry analysis of V6.5 ESC-derived EBs at day 6 of
differentiation revealed a discreet a side population of SSEA1+/
cKit+ cells (Figure 1D). A side population of Oct4-Gfp+/cKit+
cells was also identified beginning at day 6 of differentiation in EBs
derived from Oct4-gfp ESCs, and this was sustained to day 8
(Figure S1C).
To interrogate PGC identity in specific fractions of SSEA1+/
cKit+ cells when the population is first identified at day 6, we used
real time PCR to determine relative levels of PGC-expressed genes
in discreet cKit+ fractions. These fractions include SSEA1+/
cKit
bright (green), SSEA1+/cKit
mid (light blue), and SSEA1+/
cKit
dim (dark blue), and SSEA1-/cKit- cells (red) as a negative
control (Figure 1E). cKit
bright cells were selected based on
increased signal intensity above the main population. PGC genes
including cKit, Blimp1, Stella and Dazl were all enriched in the
SSEA1+/cKit
bright fraction, with lower expression in the cKit
mid
and cKit
dim fractions of SSEA1+ cells (Figure 1F). Mvh was also
expressed in the SSEA1+/cKit
bright fraction, but was not
specifically enriched in SSEA1+/cKit
bright cells relative to cKit
mid
and cKit
dim. Furthermore, analysis of Mvh levels in SSEA1+/
cKit
bright cells at day 8 of differentiation also did not show an
increase relative to day 6 (data not shown). In contrast,
transcription factors expressed in somatic cells such as Hoxa1
and Hoxb1 were highly expressed in SSEA1-/cKit- and SSEA1+/
cKit
dim relative to SSEA1+/cKit
bright cells. Together, we conclude
that not every SSEA1+/cKit+ cell in EBs at day 6 of
differentiation is a putative PGC, and that selecting for cKit
bight
cells enriches for the iPGCs beginning at day 6 of differentiation
and persisting until day 8. We next determined if Oct4-gfp could
further sub-fractionate the putative SSEA1+/cKit
bright putative
iPGC population, and found equal enrichment of Oct4-gfp in all
SSEA1+ cells regardless of cKit intensity (Figure S1D). Therefore
the use of the Oct4-Gfp reporter together with SSEA1 and cKit
does not further refine the isolation of putative iPGCs, but instead
shows that Oct4-Gfp and SSEA1 report the same population
when used with cKit.
We next evaluated the yield of SSEA1+/cKit
bright or Oct4-
gfp+/cKit
bright cells (called iPGCs) isolated at day 6 of differen-
tiation (Figure 1G). We determined that 1–4% of total live EB cells
exhibited an iPGC surface signature, and there was no statistical
difference between genetic backgrounds (Figure 1G). Furthermore,
gene expression profiling of Oct4-gfp+/cKit
bright cells from the
Oct4-gfp line and SSEA1+/cKit
bright cells from J1 EBs at day 6
revealed enriched expression of cKit, Stella, Blimp1, Dazl and Mvh
relative to the SSEA1-/cKit- somatic cell controls (Figure S1E).
Conversely, somatic gene expression as documented by Hoxa1 and
Hoxb1 were not enriched in the putative iPGCs relative to somatic
cells (Figure S1F).
To test identity of SSEA1+/cKit
bright cells derived from V6.5
ESCs we sorted putative iPGCs and cultured them on mouse
embryonic fibroblasts (MEFs) supplemented with basic Fibroblast
Growth Factor 2 (FGF2), Stem Cell Factor (SCF), Leukemia
Inhibitory Factor (LIF) and retinoic acid (RA), a driver of PGC
proliferation (Figure 1H). This assay has been used previously to
confirm PGC identity relative to undifferentiated ESCs, which
respond to RA by undergoing differentiation and becoming
alkaline phosphatase (AP) negative [15,19,20]. AP+ colony
forming ability is almost exclusively associated with SSEA1+/
cKit
bright population when compared to sorted undifferentiated
ESCs, SSEA1+/cKit
mid or SSEA1+/cKit
dim cells plated at
equivalent numbers (Figure 1I). The three non-iPGC populations
generate mostly mixed colonies or AP negative colonies.
Withdrawal of RA, FGF2 and SCF while retaining LIF in the
media of RA-treated SSEA1+/cKit
bright sorted cells results in the
formation of self-renewing pluripotent embryonic germ cells
(EGCs), which could be maintained for at least 10 passages
(Figure 1J).
Day 6 iPGCs have a pre-gonadal, pre-reprogrammed PGC
identity
Day 6 EB-derived SSEA1+/cKit
bright or Oct4-Gfp+/cKit
bright
iPGCs consistently express Dazl and Mvh RNA in addition to
Blimp1 (Figure 1F & Figure S1E). Therefore we could hypothesize
that putative iPGCs correspond to newly colonized PGCs that
have expressed Mvh protein and have potentially undergone
whole genome reprogramming. To address this, we performed
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PGCs at e11.5 [27,28,29]. We also evaluated DNA demethylation
at imprinted and non-imprinted genes, which is erased by e12.5
[30,31]. Immunofluorescence analysis of e10.5 embryos with
antibodies against Mvh and Oct4 confirms that e10.5 Oct4-
positive PGCs are negative for Mvh protein, whereas gonadal-
stage PGCs are Mvh positive (Figure 2A). Analysis of SSEA1+/
cKit
bright sorted iPGCs derived from V6.5 ESCs reveals that Mvh
protein is not detectable above background (Figure 2B). We also
tested J1 ESC-derived iPGCs and were unable to detect Mvh
protein similar to V6.5 iPGCs (data not shown). Furthermore we
evaluated H3K27m3 in SSEA1+/cKit
bright iPGCs, a histone
modification that is depleted from the PGC genome from e11.5–
e12.5 [4]. We found a high nuclear content of H3K27me3 in
iPGCs (Figure 2C). Together this data suggests that the SSEA1+/
cKit
bright iPGCs are pre-reprogrammed and younger than e11.5.
Figure 1. Transgene-free method for isolating iPGCs from embryoid bodies. A: V6.5 embryoid bodies in hanging drops at days 4, 5, and 6
of differentiation. Scale bar=500 microns. B: Oct4-Gfp expression (red) relative to V6.5 EBs (black) at days 4, 5 and 6 of differentiation. Arrows indicate
shoulder of Oct4-Gfp
bright cells at day 5 and an Oct4-Gfp
bright peak at day 6. C: Immunofluorescence of EBs at day 6 for Oct4 (red) and SSEA1 (green).
Double positive cells localize in discreet clusters (arrow). Scale bar=20 microns. D: Flow cytometry plot of V6.5 day 6 EBs stained for SSEA1 and cKit.
Oval gate defines the SSEA1+/cKit+ side population. E: Flow plot day 6 EBs from V6.5 ESCs fractionated by expression of SSEA1 and cKit into SSEA1+/
cKit
bright (green), SSEA1+/cKit
mid (light blue), SSEA1+/cKit
dim (dark blue), and SSEA1-/cKit- cells (red) populations. Quadrant gates are drawn to
demonstrate the criteria for selecting SSEA1+/cKit
bright cells. The remaining cKit+ population was split into two equal fractions, mid and dim. F: Semi-
quantitative real-time PCR from the populations isolated in E, with levels normalized to Gapdh. SSEA1+/cKit
bright cells are set at 1.0. Data is from two
biological replicates each performed in technical duplicate. Error bars represent s.e.m. G: Percentage of live iPGCs acquired from differentiation of
ESCs of different genetic backgrounds. Each line was tested at least seven independent times. H: Diagrammatic representation of iPGC replating
assay. I: Quantification of alkaline phosphatase (AP) staining of colonies derived from indicated cell populations after 5 days of culture. Right,
representative images of colony types. Scale bar=500 microns. J: Self-renewing EGCs at passage 10 derived from RA/FGF2/LIF/SCF cultured iPGCs,
followed by routine passaging in the presence of LIF only. Error bars represent s.d.
doi:10.1371/journal.pone.0028960.g001
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evaluated the methylation status of an imprinted gene (Snrpn)a n d
two non-imprinted loci, Xist and Intracisternal A Particle 1 (IAP),b y
bisulfite sequencing (Figure 2D). Analysis of undifferentiated
ESCs shows that the differentially methylated region (DMR) of
Snrpn is 49.6% methylated, the Xist promoter is 66.3%
methylated, and IAP is 83.5% methylated. In the putative iPGCs,
methylation at the Snrpn DMR is modestly reduced to 38.7%,
while Xist and IAP methylation levels are the same as ESCs. To
determine if the DMR of Snrpn also exhibits partial demethylation
in endogenous PGCs, we performed bisulfite sequencing of sorted
PGCs from e9.5 and e10.5 Oct4-gfp embryos. Methylation at the
Snrpn DMR in e9.5 and e10.5 PGCs from the embryo were still
present (47.6% and 54.2% respectively) consistent with previously
published findings [31]. Furthermore, we observed evidence of
demethylation at the 59 and 39 ends of three clones in endogenous
PGCs at e9.5 and two sequences at e10.5 similar to what was
observed in iPGCs (Figure 2D, arrows). Taken together, using
real time PCR, immunofluorescence and bisulfite sequencing, our
data strongly argue that the Blimp1-positive PGCs isolated from
EBs at day 6 of differentiation correspond to a pre-e11.5 stage
germ cell in vitro.
Germ line signature genes including Blimp1 are co-
expressed in single SSEA1+/cKit
bright cells
To determine whether the relative levels of PGC signature
genes in SSEA1+/cKit
bright cells are comparable to the levels
found in PGCs sorted from the embryo prior to e11.5, we sorted
Gfp+ cells from Oct4-gfp embryos at 9.5 and e10.5 (Figure 3A–C,
shown is e9.5). A distinct Gfp+ population was detected from e9.5
to at least e13.5 (Figure 3C and data not shown). Sorted Oct4-gfp+
PGCs from the embryo are SSEA1+ and exhibit bright cKit+
staining (Figure 3C). We confirmed that the Gfp+ cells are PGCs
due to enriched expression of cKit, Blimp1, Stella, and Mvh relative
to the Gfp- somatic cells at a population level by real time PCR
(Figure 3D). Detection of cKit and Blimp1 RNA in the Gfp-
population was not unexpected as these genes are also expressed in
endothelial and hematopoietic cells during early embryogenesis
[32,33].
We next evaluated the transcriptional identity of undifferenti-
ated ESCs, iPGCs and embryonic PGCs at e9.5 and e10.5 at a
single cell level by examining expression of five signature PGC
markers (Blimp1, Stella, Prdm14, Dnd1 and Dazl) using the BioMark
Fluidigm Real Time PCR platform (Figure 3E–H). We evaluated
38 single undifferentiated ESCs (Figure 3E), 34 single embryonic
Oct4-Gfp+ PGCs at e9.5 (Figure 3F), 24 single Oct4-Gfp+ PGCs
at e10.5 (Figure 3G), and 30 iPGCs from day 6 EBs (Figure 3H).
In undifferentiated ESCs, 17 of the 38 cells (44%) expressed
Blimp1. Of the 17 Blimp1+ cells, 6 did not express Stella and 12 did
not express Dnd1. In contrast to ESCs where less than 50% of cells
expressed Blimp1, 100% of e9.5 and e10.5 PGCs from the embryo
and iPGCs expressed Blimp1 (Figure 3F–H). Heat maps of the
single cell analysis indicate that e9.5 PGCs are relatively
homogeneous when comparing individual cells to each other for
each gene, whereas at e10.5 and in iPGCs expression levels
between individual cells is more heterogeneous (Figure 3G,H).
Critically, only one cell in the iPGC cohort was not a germ cell
(Figure 3H, asterisk).
Figure 2. iPGCs have characteristics of pre-gonadal, pre-reprogrammed in vivo PGCs. A: Immunofluorescence of pre-gonadal e10.5 PGCs
stained for Oct4 (red) and Mvh (green). e13.5 male gonadal PGCs were stained as a positive control. Dotted circles mark the testis cords. B: Sorted
SSEA1+/cKit
bright iPGCs stained for Mvh (green, left) or secondary antibody alone (right). C: iPGCs stained for H3K27m3 (red, left), and secondary
antibody alone (right). Arrows point to individual iPGCs. D: Bisulfite sequencing of ESCs, iPGCs, and endogenous e9.5 PGCs for Snrpn, the Xist
promoter, and IAP. Circles represent individual CG dinucleotides, black=methylated and white=unmethylated cytosines. Arrows indicate individual
alleles that display characteristic demethylation. N.D.=not determined.
doi:10.1371/journal.pone.0028960.g002
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28960Figure 3. Developmental staging of pre-gonadal iPGCs at single cell resolution. A: Bright field image of representative e9.5 Oct4-gfp
embryo. Dotted line indicates where the embryo was bisected at somite 13 for FACS. Scale bar=1 mm. B: Whole mount confocal microscopy of live
embryos with migratory Oct4-gfp+ PGCs within the hindgut (arrows). C: Flow cytometry of the bisected lower half of e9.5 Oct4-gfp embryos. Oct4-
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that co-expressed Blimp1, Stella, Dnd1, and Prdm14 relative to levels
in SSEA1+/cKit
bright iPGCs. We first compared ESCs to iPGCs
and found that of the 4 Blimp1+ ESCs that co-expressed Stella,
Prdm14 and Dnd1 (10.5%), the transcript levels were significantly
lower than those in iPGCs (Figure 3I–L). However, comparison of
iPGCs to embryonic e10.5 PGCs revealed no significant difference
with regard to Blimp1, Prdm14, and Dnd1 expression levels
(Figure 3I,K–L). In single cells that also co-expressed Dazl, ESCs
displayed significantly diminished Dazl levels, but no significant
difference was found between iPGCs and e10.5 endogenous PGCs
(Figure 3M). Stella levels were statistically different between all
groups, with SSEA1+/cKit
bright iPGCs on average expressing
intermediate levels between e9.5 and e10.5 embryonic PGCs
(Figure 3J). We propose that the intermediate levels of Stella in
iPGCs between e9.5 and e10.5 PGCs may indicate that iPGCs are
developmentally equivalent to a period of germ cell differentiation
between e9.5 and e10.5.
Gene expression profiling by microarray reveals iPGCs
repress a mesoderm transcriptional program and
identifies a novel marker of in vitro PGC formation from
ESCs
Although analysis of five critical PGC-expressed genes at a
single cell level was informative for ensuring that .96% of
SSEA1+/cKit
bright iPGCs have a Blimp1+ PGC identity, our next
goal was to obtain a more comprehensive transcriptional portrait
of iPGCs derived from day 6 EBs by performing microarray
analysis using Affymetrix Mouse Genome chips followed by D-
Chip analysis and examine expression of ESC-expressed genes and
somatic genes (Figure 4A,B). We profiled the SSEA1+/cKit
bright
gfp+ PGCs (circled gate) are also positive for SSEA1 and cKit. D: Real-time RT-PCR of Gfp+ and Gfp- cells. Error bar denotes s.d. E–H: Gene expression
analysis at single cell resolution for ESCs (E), e9.5 PGCs (F), e10.5 PGCs (G), and iPGCs (H) represented as a heat map of CT values with expression
ranging from not detected (black) to high (yellow). A cell titration was performed as a control to ensure linear amplification of each primer set. Each
cell was evaluated for the expression of each gene in technical triplicate. I–M: Semi-quantitative analysis of single cell real time PCR in E–H of cells
that co-express Blimp1, Stella, Prdm14, and Dnd1 expressed relative to the average delta CT expression level for each gene in single iPGCs. *p,1e-03,
**p,1 e-04, ***p,1 e-06, NS=not significant.
doi:10.1371/journal.pone.0028960.g003
Figure 4. Transcriptional profiling demonstrates a PGC program and identifies novel markers for bona fide iPGCs from ESCs. A:
Microarray analysis comparing iPGCs (A,B,C,D), V6.5 ESCs (E and F), and the somatic cells of the EB (G through J). Genes differentially expressed by
threefold between undifferentiated ESCs and iPGCs are shown (p,0.01). Red indicates significant up-regulation, green repression and black no
change. B: Semi-quantitative RT-PCR validation of microarray in Oct4-Gfp/cKit
bright iPGCs versus Gfp-/cKit- somatic cells. ND=no transcript detected.
C: Real time RT-PCR of Id4 in V6.5 ESCs (set to 1.0) compared to iPGCs. D: Immunohistochemistry of day 6 V6.5 EBs for SSEA1 (blue) and Id4 (brown,
arrows). Dotted black line denotes SSEA1+ cluster within the EB. Scale bar=10 microns. E: Immunohistochemistry of e10.5 embryos. Id4 is expressed
in SSEA1+ PGCs (arrows) and somatic cells. Scale bar=20 microns. Negative controls were performed with secondary antibodies alone.
doi:10.1371/journal.pone.0028960.g004
Developmental Staging of In Vitro PGCs
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28960fraction from V6.5 EBs at day 6 of differentiation (Samples A and
B), Oct4-Gfp+/cKit
bright cells from day 6 Oct4-gfp EBs (Samples C
and D), undifferentiated V6.5 SSEA1+/cKit+ ESCs (Samples E
and F), and SSEA1-/cKit- and Oct4-/cKit- day 6 EB cells
(Samples G–J).
Cluster analysis of genes that are differentially expressed at
greater than three-fold between undifferentiated ESCs and iPGCs
(348 genes, p,0.01) generated four major transcriptional clusters
(Figure 4A & Table S1). Gene ontology (GO) analysis of Cluster I
(enriched in ESCs but not iPGCs or somatic cells) identified genes
associated with transcription factor activity and DNA binding.
Cluster II (enriched in iPGCs but not ESCs or somatic cells)
revealed enrichment in genes associated with hydrolyase activity,
cytoplasmic proteins and MAPK signaling pathways. Genes in
Cluster III (enriched in ESCs and somatic cells but not iPGCs)
were associated with GO terms for stress fibers and actin filament
bundle genes. Finally, GO analysis of Cluster IV (repressed in
iPGCs and ESCs but not somatic cells) revealed genes associated
with mesoderm formation including heart and blood development,
and morphogenesis. Together, these data suggest that iPGCs
repress genes associated with mesoderm differentiation, similar to
what has been proposed for endogenous PGC formation through
the activity of Blimp1 [2,7]. Expression of candidate PGC genes
from the microarray was validated by real time RT-PCR from
Oct4-Gfp+/cKit
bright iPGCs (Figure 4B). Similarly, expression of
additional somatic genes (Hoxa2 and Hoxc5) which were not
evaluated earlier (Figure S1F) revealed undetectable expression in
iPGCs, whereas somatic cells were positive.
Next, we compared our microarray data between iPGCs and
undifferentiated ESCs to identify a marker that could distinguish
between these two cell types. We identified Inhibitor of DNA binding
4 (Id4) as being significantly higher in iPGCs relative to ESCs. We
confirmed the microarray data showing significant enrichment of
Id4 RNA in independently collected iPGC samples relative to
undifferentiated ESCs (Figure 4C). To determine if Id4 protein is
expressed in iPGCs, we performed immunohistochemistry of day 6
EBs with SSEA1 and Id4, and identified Id4 positive cells within
the clusters of SSEA1+ cells (Figure 4D). Likewise, immunohis-
tochemistry of e10.5 embryos shows that Id4 protein is expressed
in SSEA1+ PGCs (Figure 4E, arrow). However, Id4 was also
expressed in the surrounding embryonic somatic cells. Taken
together, Id4 is a new marker for distinguishing iPGCs from
undifferentiated ESCs, but does not distinguish PGCs from
somatic cells of the embryo.
Blimp1 is specifically required for iPGC differentiation
from EBs
Dosage of Blimp1 is essential for the specification of PGCs in vivo
[2,32]. To determine if the emergence of SSEA1+/cKit
bright PGCs
in vitro is similarly dependent upon Blimp1 expression, we derived
Blimp1
fl/fl ESCs from e3.5 blastocysts. We performed Y chromo-
some FISH to identify a male line (Figure 5A), and generated three
independent Blimp1 knockout sub-lines (Blimp1
D/D) via transfection
of Cre recombinase fused to Gfp followed by re-plating of Gfp+
cells at limiting dilutions. Clones were screened by Southern blot
to verify Blimp1 deletion (Figure 5B). To compare overall self-
renewal and pluripotency in Blimp1
D/D cells relative to the parental
line, we performed flow cytometry for SSEA1 under self-renewing
conditions in the presence of LIF (Figure 5C), and teratoma
analysis by injection of undifferentiated ESCs into the testicles of
SCID mice (Figure 5D). In both assays, all Blimp1
D/D lines were
indistinguishable from parental Blimp1
fl/fl cells, indicating that loss
of Blimp1 does not cause gross defects in overall ESC self-renewal
or differentiation.
Finally, to evaluate in vitro PGC formation, we performed paired
differentiation experiments with Blimp1
fl/fl and Blimp1
D/D lines and
evaluated iPGC differentiation by flow cytometry (Figure 5E).
Quantification of SSEA1+/cKit
bright cells revealed that iPGCs
constitute approximately 3–4% of the live cell EB population in
the parental Blimp1
fl/fl line at day 6 (Figure 5F). In contrast, all
Blimp1
D/D sub-lines displayed between a 70–90% decrease in
SSEA1+/cKit
bright iPGCs, with the average percentage constituting
less than 1% of the EB in all three sub-lines examined (Figure 5F,G).
Functionally, this demonstrates that sorting for SSEA1+/cKit
bright
iPGCscapturesaBlimp1-dependentPGCpopulationinvitro,w h er ea s
generation of SSEA1+/cKit
mid and SSEA1+/cKit
dim fractions of
EBs do not exhibit the same reliance on Blimp1 as in vivo PGCs.
Discussion
Emerging cell populations in the early embryo are challenging
to investigate. Therefore, we used mouse ESCs from multiple
genetic backgrounds to differentiate transgene-free, pre-gonadal
stage PGCs where 100% of the single iPGCs express Blimp1 in vitro.
Here we show that sorting for the cKit
bright fraction of SSEA1+
cells at day 6 of differentiation when the population is first
discernable yields an iPGC population with an identity suggestive
of PGCs younger than e11.5.
One of the major challenges in the ESC and PGC fields has
been to distinguish early progenitor PGCs from undifferentiated
ESCs due to their similar expression patterns. Indeed, e11.5 PGCs
isolated from the genital ridge prior to sex determination cluster
very closely to undifferentiated ESCs in 2-dimensional principle
component analysis after microarray [11]. Therefore, it has been
proposed that ESCs originate from a progenitor germ cell
consistent with detectable expression of PGC-signature genes,
including Dazl and Tissue non specific alkaline phosphatase in the
undifferentiated state [34,35]. Although our studies do not address
the origin of ESCs, our data does indicate that a small nascent
PGC-like population corresponding to about 10% of cells can be
identified in an ESC culture in the self-renewing state, agreeing
strongly with previous work which demonstrated that Dazl null
ESCs exhibit reduced expression of PGC-signature genes [8].
However, our data also show that despite co-expression of germ
cell genes in these 10% of cells, the transcript levels are
significantly lower than the levels found in bona fide PGCs isolated
form the embryo between e9.5–e10.5 as well as the iPGCs. Taken
together, our data argues that the majority of undifferentiated
ESCs are not PGCs, and that a single cell analysis is critical to
uncouple differences between ESCs and progenitor PGCs.
In the current study, we identified Id4 as a new marker enriched
in iPGCs relative to undifferentiated ESCs. Id4 was recently found
to be a germ line marker expressed in gonocytes and spermato-
gonia of postnatal and adult murine gonads [36]. We extend these
findings to show that Id4 is expressed during the earliest stage of
germ line development, prior to gonadal colonization (Figure 4E).
Interestingly, Id4 similar to Stella constitutes a marker for defining
PGC identity yet has no functional role in specifying PGC fate
[13,36,37]. However, by combining Id4, SSEA1, and Oct4
expression in day 6 EBs, we propose a model for germ line
formation in vitro that involves the generation of multiple SSEA1+/
Oct4+ niches during EB formation, with Id4+ iPGCs emerging
from within these niches (Figure 6). We propose that similar to
PGC development in the allantois of the embryo, the tight
clustering of SSEA1+/Oct4+ cells creates a microenvironment in
the EB to protect the iPGCs against somatic cell differentiation
signals [38]. Given that Id4+ cells constitute only a subpopulation
of cells within SSEA1+ clusters, we hypothesize that the clusters
Developmental Staging of In Vitro PGCs
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28960are composed of a heterogeneous mixture of immature cells,
including epiblast-like cells (Stella negative, Blimp1 negative), PGC
precursors (Stella negative, Blimp1 positive) and definitive Id4-
positive cKit
bright iPGCs (Figure 6). Whether the SSEA1+/
cKit
bright PGCs emerge from a subpopulation of the SSEA1+/
cKit
mid fraction of cells remains to be determined. However, our
data strongly argue that iPGCs do not differentiate from SSEA1+/
cKit
dim cells, which have no colony forming potential, and express
high levels of Hoxa1 and Hoxb1, indicating commitment to a
somatic fate.
Although our data suggest that the iPGCs are younger than
e11.5 of development due to lack of Mvh protein expression, it is
conceivable that iPGCs at day 6 are more similar to e11.5 in some
aspects, but have not received the appropriate cues to express Mvh
protein. The signals that promote Mvh protein expression in
PGCs at e11.5 are not well understood, but one study has
indicated that gonadal somatic cells are involved in this process
[29]. Lack of Mvh protein expression in our model suggests that
the hanging drop EB system by day 6 of differentiation does not
provide the necessary signals to promote developmental progres-
sion to Mvh protein-positive iPGCs. This result implies that
progression of iPGCs in vitro may require a gonadal niche to
promote differentiation to the Mvh protein-positive stage. Indeed,
while this manuscript was under review, Hayashi and colleagues
demonstrated that a neonatal seminiferous tubule niche was
necessary to promote differentiation of ESC-derived PGCs, which
this group called PGC like cells (PGCLCs), into functional post-
meiotic male germ cells [39]. In these studies, PGCLCs were
isolated using SSEA1 and Integrin Beta 3 and were hypothesized
to be equivalent to e9.5 of development. Similar to this group,
iPGCs isolated at day 6 also express significantly high levels of
Integrin Beta 3 RNA (Figure S2).
In the current study, we successfully acquired PGCs in the
Blimp1-positive stage of development. Blimp1 is not expressed in
Figure 5. Blimp1 is required for the differentiation of iPGCs from ESCs. A: DNA-FISH for the Y chromosome in Blimp1
fl/fl ESCs. B: Southern
blot for detection of wild type (WT), flox, and knock-out (KO) alleles of Blimp1. C: Flow cytometry for SSEA1 on undifferentiated ESCs. D:
Representative histological sections from Blimp1
fl/fl and Blimp1
D/D teratomas. All lines were capable of differentiation to ectoderm (Ecto), mesoderm
(Meso) and endoderm (Endo). Scale bar=100 microns. E: Representative paired EB differentiations of Blimp1
fl/fl and Blimp1
D/D ESCs. Quadrant gates
indicate criteria for gating SSEA1+/cKit
bright iPGCs, which are contained within the rectangular gate (black lines). F: Percentage iPGC yield in the
control Blimp1
fl/fl line and Blimp1
D/D sub-lines. Error bars represent s.e.m. G: Quantification of data from F, expressed as a percent of the Blimp1
fl/fl
iPGC yield from each paired experiment. Error bars represent the standard error of the mean. *p,0.05, ** p,1610
27.
doi:10.1371/journal.pone.0028960.g005
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for evaluating meiotic progression; however, we propose that this
model can be used to successfully evaluate molecular events in PGC
formation prior to gonadal colonization, gonadal reprogramming
and sex determination. As an example of the utility of our model,
one hundred male e10.5 embryos would be required to obtain
approximately 100,000 PGCs via FACS, if we estimate that there
are ,1,000 PGCs per embryo at this developmental age [5]. In
contrast, generating iPGCs equivalent to e9.5–10.5 of development
using ESC differentiation required 50 plates of hanging drop EBs,
which takes 1 hour to set up from only two wells of undifferentiated
ESCs. This yields on average 150,000–175,000 Blimp1 positive
iPGCs at day 6 of differentiation, resulting in more than 100-fold
enrichment in cell numbers over embryonic dissections [40].
In conclusion, we propose that the ESC-to-PGC differentiation
model is an essential tool for examining molecular events in PGC
development. In this study we developed a model that specifically
captures the Blimp1-positive stage of male PGC formation prior to
the expression of Mvh protein. This period of germ cell
development (prior to e11.5) is uniquely regulated in mammals
and is not conserved with lower model organisms such as
Drosophila, C. elegans, frog, and chick (for example, the role of
Blimp1). Therefore, creating models that study the initial formation
of mammalian PGCs such as the one described here, as well as
extending this model to female ESC lines, will be critical to our
understanding of the mechanisms that govern fundamental
principles of inheritance via the germ line.
Materials and Methods
Ethics Statement
Mouse embryo dissection, breeding colony maintenance, and
animal surgery were all performed following Institutional Approval
for Appropriate Care and use of Laboratory animals by the UCLA
Institutional Animal Care and Use Committee (Chancellor’s
Animal Research Committee (ARC)), Animal Welfare assurance
number A3196-01.
Cell Culture and EB Differentiation
All ESC lines in this study were maintained as described
previously with lot-tested FBS (Hyclone Lot #ATJ33070) on
inactivated CF-1 mouse embryonic fibroblasts (MEFs) [41]. Cells
were passaged every three days at 5,300 cells/cm
2. For EB
formation, ESCs were subjected to MEF depletion by plating a
single cell suspension on tissue culture dishes twice for five minutes
each. Cells were seeded in drops of 20 microliters each containing
300 cells on the lids of Petri dishes with 5 mL PBS in the plate
bottom and cultured in the absence of LIF for six days, with
addition of 3.5 mL PBS on day 3 of differentiation. For ESC
derivation, e3.5 blastocysts were isolated from homozygous
Blimp1
flox/flox (C57BL6/J) crosses and cultured in ESC media
containing PD98059 (Cell Signaling) for four days. ESC lines were
then passaged and maintained routinely. To generate Blimp1 null
ESCs, Blimp1
flox/flox cells were transfected with pCAG-Cre:Gfp
[42] and sorted to generate sublines.
Mice
Oct4-gfp embryos were dissected and dissociated with TrypLE
(Invitrogen) prior to flow cytometry or FACS. For teratoma
analysis, 100,000 ESCs were injected into the testicles of SCID
recipient mice and collected 6 weeks after transplant for histology
[40].
iPGC Colony Assay
iPGCs were sorted from EBs by FACS and re-plated on
inactivated CF-1 MEFs. iPGCs were cultured in ESC media
Figure 6. Model for iPGC emergence from SSEA1/Oct4+ clusters in EBs. In day 6 of EBs (pink circle) multiple discreet clusters of Oct4+ (red)
and SSEA1+ (green) cells are identified. SSEA1+ cells within these clusters exhibit a range of cKit signal intensities identified by flow cytometry
including cKit
bright (iPGCs), cKit
mid (iPGC precursors and epiblast stem cells) and cKit
dim (somatic lineage primed epiblast) cells (black box). Definitive
iPGCs are enriched in the cKit
bright fraction of SSEA1+ or Oct4+ cells, and the generation of this population in vitro is dependent upon Blimp1. Using a
differential colony forming assay in the presence FGF2, SCF, LIF and RA which promotes survival and proliferation of PGCs, we show that RA-iPGC
potential is highest in the cKit
bright fraction and is absent in the cKit
dim subpopulation of SSEA1+ cells. Furthermore, converting RA-iPGCs to media
containing LIF supports the generation of self-renewing EGCs in vitro.
doi:10.1371/journal.pone.0028960.g006
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21 bFGF2 (R&D), 30 ngml
21 SCF
(Peprotech), and 2 micromolar retinoic acid (Sigma), for five days
as described previously [15]. Cells were cultured for five days with
daily media changes followed by assaying for AP activity. EGCs
were derived from iPGCs by culture of iPGCs for five days with
LIF/SCF/bFGF2/RA, followed by passaging in LIF-only con-
taining media for subsequent passages.
Flow cytometry and FACS
Staining for SSEA1 (DSHB, 1:200) and cKit (BD, 1:200) was
performed on ice. Indirect labeling was performed with Cy5-
conjugated goat anti-mouse IgG and IgM (1:500) and PE-
conjugated goat anti-rat IgG (1:1000) (Jackson ImmunoResearch).
7AAD or DAPI were added prior to all acquisitions to examine
only live cells for downstream analyses with FlowJo software
(TreeStar).
Immunostaining
Embryoid bodies were fixed and embedded in paraffin
according to standard protocols. For iPGC stains, cells were
sorted by FACS and plated onto poly-lysine coated cover slips.
The following antibodies were used at the indicated dilutions:
SSEA1 (DSHB, 1:100), Oct4 (1:100, Santa Cruz), Mvh (1:100,
Abcam), and H3K27m3 (1:500, Millipore). All samples were
incubated with primary antibodies overnight at 4uC. Sections were
washed, incubated with FITC anti-mouse IgM, TRITC anti-goat
IgG, or FITC/TRITC conjugated anti-rabbit IgG antibodies
(Jackson Immunoresearch) for 30 minutes at room temperature. Y
chromosome FISH was performed on chromosome spreads.
SSEA1 and Id4 immunohistochemical detection was performed
using anti-Id4 (1:100, Novus Biologicals) and anti-SSEA1 (DSHB)
with standard protocols (Vector Labs).
Real-time PCR
RNA was extracted from sorted samples using the RNEasy
Micro Kit (Qiagen) and reverse-transcribed using Superscript RT
II (Invitrogen). All gene expression analysis was performed using
commercially available TaqMan Gene Expression Assays (Applied
Biosystems), with the exception of Id4, which as examined by
SYBR Green PCR (Roche). See Table S2 for additional primer
information. CT values were normalized to Gapdh expression and
expressed as fold change relative to a control cell type referenced
in each experiment.
Single-cell Real Time RT-PCR
Single cells were sorted by FACS and subjected to reverse
transcription and specific target amplification of relevant genes
using the Fluidigm BioMark 48.48 dynamic gene expression
system according to manufacturer’s instructions, with PCR
performed by the UCLA Genotyping and Sequencing core
facility. A dilution series of cells were used as detection controls
and also to establish primer correlation coefficients and ensure
linear amplification of amplicons. Heat map data was generated
using Fluidigm Real Time PCR Analysis software.
Microarray and Data Analysis
RNA extraction, labeling amplification and hybridization to
Affymetrix Mouse Genome 430 2.0 arrays were performed as
previously described [41]. Analysis was performed using model-
based expression and invariant set probe normalization using D-
Chip software [43]. Gene ontology (GO) terms were identified
using DAVID [44,45]. Microarray data is deposited under GEO
accession number GSE33121.
Bisulfite Sequencing
Genomic DNA was isolated from sorted samples (Zymo
Research). Bisulfite conversion was performed using the EZ
DNA Methylation Kit according to manufacturer’s instructions
(Zymo Research). PCR was performed on bisulfite converted
genomic DNA and cloned into pCR2.1-TOPO (Invitrogen).
Clones were sequenced and aligned using Lasergene software
(DNASTAR). See Table S2 for PCR primer information.
Southern Blot
Prdm1/Blimp1 deletion was verified with dUTP-digoxigenin-
labeled probe generated by PCR upstream of the deleted exons of
Blimp1 (fwd:59- CTCGTGGCTCTTGTGTGTGT -39, rev:59-
AACGCTGTACCCATGACTCC -39), after digestion with
EcoRI. Detection of wild type (15 kb), flox, (13.5 kb), and KO
(10 kb) alleles of Blimp1 have been described [46].
Supporting Information
Figure S1 Kinetics of EB formation and the transcrip-
tional identity of iPGCs. A: Oct4-gfp embryoid bodies at days
5–8 of differentiation. Scale bar=500 microns. B: Quantification
of EB cell viability recorded as the percent of 7AAD- cells at each
time point by flow cytometry. C: Flow cytometry of the live cell EB
fraction for Oct4-gfp and cKit at the corresponding time point.
Blue oval indicates the Oct4-gfp+/cKit+ side population, which
first appears at day 6. Oct4-gfp+/cKit
bright cells correspond to
iPGCs. D: Oct4-gfp EBs at day 6 were stained with SSEA1 and
cKit, and Oct4-gfp expression was examined in SSEA1+/
cKit
bright, SSEA1+/cKit
mid and SSEA1+/cKit
dim populations. E:
PGC gene expression data for Oct4-gfp and J1-derived iPGCs and
somatic cells. F: Somatic gene expression data for Oct4-gfp and J1-
derived iPGCs and somatic cells.
(TIF)
Figure S2 Integrin Beta 3 is enriched in iPGCs. Normal-
ized signal intensity from probe sets for Integrin beta 3 (Itgb3) for
ESCs and iPGCs were determined from the microarray presented
in Figure 4A.
(TIF)
Table S1 DAVID Gene Ontology of transcriptional clusters
identified between ESCs and iPGCs. Gene ontology analysis of
genes corresponding to Affymetrix probe sets identified from each
transcriptional cluster in Figure 4A differentially expressed more
than 3-fold with p,0.01.
(DOC)
Table S2 Primers used in this study.
(DOCX)
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